9. Diabetes Year 2

36
7/21/2019 9. Diabetes Year 2 http://slidepdf.com/reader/full/9-diabetes-year-2 1/36 Pharmacist’s Role in the Management of Dipa Kamdar 

description

diabetesyear 2

Transcript of 9. Diabetes Year 2

Page 1: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 1/36

Pharmacist’sRole in the

Management of

Dipa Kamdar 

Page 2: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 2/36

Learning Objectives Students should be able to:

 Describe the prevalence of diabetes

 Discuss the management of diabetes

 Discuss the management of diabetic

complications

 Discuss the role of a pharmacist in the

management of diabetes

Page 3: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 3/36

Page 4: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 4/36

Diabetes Mellitus (DM)DM is the name given to a group of disorders wherethe circulating levels of the hormone insulin are

insufficient to maintain blood glucoseconcentrations within the normal range (4-7mmol/l*)   *varies in literature

Page 5: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 5/36

Page 6: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 6/36

3.7 million people live with Type 1 and Type 2

diabetes and 7 million people at risk of developing Type 2 diabetes in the UK 

Page 7: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 7/36

 “Around 10 per cent of NHS spending goes on

diabetes and its complications; this equates to£10 billion per year or £1 million an hour” 

Page 8: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 8/36

Complications

Page 9: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 9/36

In the UK…..

Page 10: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 10/36

Standard 4 of NSF for diabetesKey recommendations

a)   Improve blood glucose control

  Drug choice/monitoring

b)   Control hypertension

  Reduce CVD/retinopathy/nephropathy

c)   Reduce raised cholesterol levels

  Give Statin + aspirin (2o

prevention)d)   Encourage smoking cessation

  NRT; Champix

Page 11: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 11/36

Management of Diabetes

Advice regardinglifestyle changes

 Diet Exercise

 Smoking

 Alcohol

Driving

Regular checks

Page 12: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 12/36

Insulin Insulin is first line treatment for:

T1DM

T2DM when other methods havefailed to achieve good control,

Temporarily in the presence of

intercurrent illness or peri-operatively

In pregnant women with type 2diabetes when diet alone fails

Page 13: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 13/36

Types of Insulin

Short-acting

 E.g.____________________________________________ 

Immediate acting

 Human insulin analogues e.g.___________________ 

Intermediate

E.g.________________________________________ 

Long acting

E.g.________________________________________ 

Regimens  Once daily + immediate acting

 Biphasic x bd

Page 14: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 14/36

Insulin

Devices

Page 15: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 15/36

Advantages Disadvantages

Vial +

syringe

Pre-filled

pens

Penfill

cartridges

Insulin

Pump

Page 16: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 16/36

Insulin - Counselling

The following information on insulin administration should be

provided to a person with type 1 diabetes and to their familyor carers:

  Insulin absorption  — to be aware of the factors

influencing insulin absorption which can have an effect

on blood glucose control   Injection sites  — to ensure that the appropriate sites are

used for injecting insulin

  Injection technique  — to ensure that insulin is injectedcorrectly

  Injection site rotation  — to prevent lipohypertrophy

 Timing of injection  — to optimize glycaemic control

 Self injecting  — to support parents and young childrenusing self-injecting insulin

Page 17: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 17/36

Insulin – Counsellingon Lifestyle

DrivingHolidays

and travel

Ramadan

 Alcohol

Shiftwork Insurance

Sportsandexercise

Page 18: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 18/36

Monitoring

Finger-prick 

blood sample

Urine testing

 Glucose Ketones

Microalbuminurea

Hospital testing

 Glycosylated haemoglobin (HbA1c)

 6.5–7.5% (48–59 mmol/mol) or less (reference range4–6% or  20–42 mmol/mol)

Insulin Passport

Page 19: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 19/36

Future Technologies in Monitoring

Implantable long

term continuousglucose monitoring

sensor 

Light sensor

Contact lens(microchip)

Tattoo (sensors)

Breathalyser

Saliva

Earlobe Sensor

Page 20: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 20/36

Oral Antidiabetic Drugs

Used for T2DM (if not controlled by diet for 

3 months)

NICE Guidelines Pathway for T2DM Treatment

Metformin first-line

 Unless C/I, not tolerated etc.

Page 21: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 21/36

NICE Guidelines

Page 22: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 22/36

Drug Therapy

Continued…

Page 23: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 23/36

Dual Therapy

Metformin + Sulphonylurea

Or if sulphonylurea is C/I or causes severe hypoglycaemia,

try… DPP-4 inhibitor (sitagliptin, vildagliptin)

 Thiazolidinedione (pioglitazone)

 Canagliflozin

 Dapagliflozin

 Liraglutide Exenatide

Page 24: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 24/36

Control of

hypertensionNot all drugs are appropriate

Beta blockers in general should be avoided

 Mask some symptoms of hypoglycaemia

Diuretics used with caution Hypokalaemia can impair insulin release and

worsen glucose tolerance

ACE inhibitors usually drug of choice

 Especially in presence of proteinuria

 Slow progress of renal complications even inabsence of IHD or raised BP

 Useful in presence of heart failure

Page 25: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 25/36

Reducing complications

Retinopathy

Major cause of blindness

Regular eye tests

Can be managed withlaser treatment

Good glucose and BPcontrol

Refer to optometrist or ophthalmic optician

Diabetics get free eye tests

Page 26: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 26/36

Reducing complications

Nephropathy

Minimised by good glucose + BP control

Characterised by microalbuminaemia

Worsens to proteinuria

ACE inhibitor slows progression

Keeping well hydrated

Page 27: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 27/36

Reducing complications

Peripheral Vascular Disease &Neuropathy

  Provide advice on good basic footcare, avoid narrow fitting, tightshoes, etc.

  Keep toenails well trimmed, cutstraight across, etc.

  Use request for foot care productsas ‘cue’

  Seek attention ofchiropodist/podiatrist if appropriate

  Warn of danger signs e.g. pins &needles

  Get cuts, burns on feet treated

  Watch for fungal infections, etc.

Page 28: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 28/36

Complications

Hypoglycaemia

 Symptomatic if glucose <2.2mmol/L

Page 29: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 29/36

Management of Hypoglycaemia

Glucose 10-20g orally

Snack (carbohydrate)

Hypo withunconsciousness =

emergencyGlucagon

If ineffective

Glucose IVinfusion

10 mins

Page 30: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 30/36

Page 31: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 31/36

Diabetic Ketoacidosis

IV infusion soluble insulin

Fluids

Potassium

State of uncontrolled catabolismassociated with insulin deficiency(usually type 1)

Page 32: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 32/36

Role of Pharmacist

Prevention

Identificationand diagnosis

Initial assessmentand management

Ongoingcare

Preventing or 

delayingcomplications

Page 33: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 33/36

Screening in the

community

  NHS HealthCheck 

 Aged 40-74years

  If you exhibit

symptoms ofdiabetes e.g.Lethargy,polyuria, thirst

  If you havemultiple risk factors for 

diabetes e.g.Overweight,family history,ethnicity

•   Questionnaire +/- finger prick blood glucose test

•   If positive, referral to GP

Page 34: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 34/36

Medicines

Optimisation

  All appropriate drugs

prescribed? e.g. statin, ACEI

  Best choice of anti-diabetic agents?

  Correct dosage regime?

  Compliance with regime?

  Complications optimally managed?

  Education e.g. hypos, when to seek help?

  Insulin

  Dispensed correct insulin?

  Storage?

  Most appropriate device?

  Appropriate test strips & monitors? Diary?

Page 35: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 35/36

Summary

 Describe the prevalence of diabetes

 Discuss the management of diabetes

 Discuss the management of diabetic complications

 Discuss the role of a pharmacist in the management

of diabetes http://video.novonordisk.com/video/10296136/the-

challenges-of-living-with-diabetes

Page 36: 9. Diabetes Year 2

7/21/2019 9. Diabetes Year 2

http://slidepdf.com/reader/full/9-diabetes-year-2 36/36

References

  BNF – latest edition

  Clinical Biochemistry – Allan Caw et al.

  Saunder’s Pocket Essentials of Clinical Medicine – Allan Ballinger andStephen Patchett

  http://www.nice.org.uk/nicemedia/pdf/CG66FullGuideline0509.pdf

  www.diabetes.org.uk    https://www.diabetes.org.uk/upload/Professionals/Publications/Winter%20

2012/MedicineDigest-winter2012.pdf

  http://www.publications.parliament.uk/pa/cm201213/cmselect/cmpubac

c/289/289we02.htm

  https://www.gov.uk/government/uploads/system/uploads/attachment_d

ata/file/198836/National_Service_Framework_for_Diabetes.pdf

  Pearson, T. (2010) Practical Aspects of Insulin Pen Devices. Journal ofDiabetes Science and Technology. 4(3): 522-531.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901027/

  http://cks.nice.org.uk/insulin-therapy-in-type-1-diabetes#!scenario